Masashi Fujita Selected Research

triazulenone (loprazolam)

4/2019

Changes in serum levels of leucine-rich α2-glycoprotein predict prognosis in primary biliary cholangitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masashi Fujita Research Topics

Disease

29	Neoplasms (Cancer) 05/2021 - 08/2009
12	Heart Failure 11/2010 - 08/2003
10	Fibrosis (Cirrhosis) 01/2021 - 04/2006
10	Thrombosis (Thrombus) 11/2020 - 07/2002
8	Infarction (Infarctions) 04/2009 - 07/2004
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2019
7	Atrial Fibrillation 01/2020 - 09/2015
7	Ischemia 07/2013 - 07/2004
6	Bradycardia 07/2022 - 02/2009
6	Neointima 01/2019 - 01/2013
6	Myocardial Infarction 08/2017 - 06/2006
6	Reperfusion Injury 05/2009 - 10/2004
6	Myocardial Ischemia (Ischemic Heart Diseases) 09/2007 - 03/2003
4	Non-alcoholic Fatty Liver Disease 10/2020 - 01/2017
4	Liver Neoplasms (Liver Cancer) 03/2020 - 05/2018
4	Liver Diseases (Liver Disease) 01/2020 - 01/2015
4	Peripheral Arterial Disease 04/2018 - 09/2016
4	Ventricular Fibrillation 06/2015 - 01/2005
3	Autoimmune Hepatitis 07/2022 - 05/2019
3	Pulmonary Embolism 01/2022 - 08/2019
3	Ascites 12/2021 - 09/2018
3	Infections 12/2021 - 12/2017
3	Hypertension (High Blood Pressure) 09/2021 - 04/2006
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2020 - 09/2018
3	Liver Cirrhosis (Hepatic Cirrhosis) 07/2020 - 12/2017
3	Hepatitis 03/2020 - 01/2019
3	Inflammation (Inflammations) 05/2019 - 04/2006
3	Neoplasm Metastasis (Metastasis) 04/2019 - 08/2009
3	Pathologic Constriction (Stenosis) 10/2017 - 10/2010
3	Glucose Intolerance 08/2017 - 04/2006
3	Coronary Occlusion 12/2004 - 07/2004
2	Lupus Nephritis 12/2022 - 01/2022
2	Sick Sinus Syndrome 07/2022 - 09/2015
2	Fever (Fevers) 07/2022 - 01/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 08/2019
2	Thromboembolism 09/2021 - 04/2020
2	Jaundice (Icterus) 02/2021 - 12/2020
2	Hyperglycemia 01/2021 - 04/2006
2	Heart Diseases (Heart Disease) 01/2021 - 08/2003
2	Hemorrhage 01/2021 - 07/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 03/2020
2	Hepatic Encephalopathy 01/2021 - 11/2020
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 01/2019
2	Fatigue 01/2021 - 01/2020
2	Hypertrophy 03/2020 - 10/2006
2	Lymphoma (Lymphomas) 03/2020 - 01/2013
2	Liposarcoma 02/2020 - 12/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2020
2	Stroke (Strokes) 07/2019 - 08/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2019 - 09/2018
2	Hyponatremia 09/2018 - 01/2015
2	Chronic Limb-Threatening Ischemia 04/2018 - 05/2010
2	Diabetes Mellitus 04/2018 - 10/2015

Drug/Important Bio-Agent (IBA)

11	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2018
9	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2018
5	Pharmaceutical PreparationsIBA 01/2022 - 04/2005
5	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 05/2018
5	Adenosine (Adenocard)FDA LinkGeneric 02/2009 - 10/2006
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2010
3	pembrolizumabIBA 07/2022 - 01/2020
3	Immune Checkpoint InhibitorsIBA 07/2022 - 10/2020
3	lenvatinibIBA 01/2022 - 01/2020
3	EnzymesIBA 02/2021 - 06/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 09/2019
3	Circulating Tumor DNAIBA 01/2020 - 02/2019
3	Phosphotransferases (Kinase)IBA 01/2019 - 01/2005
3	Anti-Arrhythmia AgentsIBA 01/2018 - 01/2005
3	MetalsIBA 10/2017 - 10/2015
3	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2009 - 02/2006
3	5'-Nucleotidase (5' Nucleotidase)IBA 06/2008 - 10/2004
3	WortmanninIBA 06/2006 - 10/2004
3	Protein Kinase CIBA 12/2005 - 07/2004
2	Complement System Proteins (Complement)IBA 07/2022 - 01/2020
2	Gemcitabine FDA Link 01/2022 - 08/2019
2	Methylprednisolone FDA LinkGeneric 12/2021 - 02/2021
2	Tyrosine Kinase InhibitorsIBA 09/2021 - 04/2020
2	pazopanib FDA Link 09/2021 - 02/2021
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2021 - 12/2020
2	SteroidsIBA 02/2021 - 11/2008
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2021 - 07/2020
2	osimertinibIBA 01/2021 - 03/2020
2	Keratin-18 (Keratin 18)IBA 05/2020 - 09/2018
2	Sorafenib (BAY 43-9006)FDA Link 04/2020 - 09/2018
2	ChromatinIBA 03/2020 - 01/2019
2	PlatinumIBA 01/2020 - 08/2009
2	CytokinesIBA 01/2020 - 06/2009
2	Cell-Free Nucleic AcidsIBA 10/2019 - 02/2019
2	voglibose (Basen)IBA 08/2017 - 04/2006
2	Glycoside Hydrolase InhibitorsIBA 08/2017 - 04/2006
2	Oxygen (Dioxygen)IBA 01/2017 - 05/2007
2	Hemoglobins (Hemoglobin)IBA 01/2017 - 08/2009

Therapy/Procedure

30	Therapeutics 01/2022 - 08/2003
14	Stents 01/2021 - 01/2013
9	Drug Therapy (Chemotherapy) 01/2022 - 11/2008
4	Catheter Ablation 01/2018 - 09/2015
3	Percutaneous Coronary Intervention 01/2021 - 08/2017
3	Precision Medicine 10/2019 - 03/2018
2	Aftercare (After-Treatment) 01/2021 - 11/2020
2	Drug-Eluting Stents 10/2017 - 01/2014
2	Renal Dialysis (Hemodialysis) 10/2016 - 08/2009